Chemotherapy for Aggressive Juvenile Nasopharyngeal Angiofibroma
- 1 May 1985
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 111 (5) , 285-289
- https://doi.org/10.1001/archotol.1985.00800070037002
Abstract
Research from JAMA Otolaryngology–Head & Neck Surgery — Chemotherapy for Aggressive Juvenile Nasopharyngeal AngiofibromaThis publication has 12 references indexed in Scilit:
- Juvenile AngiofibromaPublished by Springer Nature ,2017
- Juvenile nasopharyngeal angiofibroma: Control rates and treatment costsHead & Neck Surgery, 1980
- Relative risk factors in the treatment of juvenile nasopharyngeal angiofibromaHead & Neck Surgery, 1980
- Improved prognosis in children with ovarian cancers following modified VAC (vincristine sulfate, dactinomycin, and cyclophosphamide) chemotherapyCancer, 1978
- Surgical management of nasopharyngeal angiofibroma with intracranial extensionThe Laryngoscope, 1977
- Risk of second tumors in survivors of childhood cancerCancer, 1975
- The Radiological Treatment of Juvenile Nasopharyngeal AngiofibromasAnnals of Otology, Rhinology & Laryngology, 1970
- Intracranial Extensions of Juvenile Angiofibroma of the NasopharynxThe Journal of Laryngology & Otology, 1967
- Juvenile nasopharyngeal fibromaThe American Journal of Surgery, 1963
- Nasopharyngeal Fibroma and its TreatmentThe Journal of Laryngology & Otology, 1954